Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travers Ching

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Nature Communications|September 28, 2017
Corrigendum: Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancerBi-Dar Wang, Kristin Ceniccola, SuJin Hwang, et al.
Nature Communications|July 1, 2017
Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancerBi-Dar Wang, Kristin Ceniccola, SuJin Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2021
Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 StudyOthman Al-Sawaf, Can Zhang, Tong Lu, et al.
BMC Cancer|July 2, 2020
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myelomaTravers Ching, Megan E Duncan, Tera Newman-Eerkes, et al.
Nature|April 30, 2015
Th17 cells transdifferentiate into regulatory T cells during resolution of inflammationNicola Gagliani, Maria Carolina Amezcua Vesely, Andrea Iseppon, et al.
Cell Chemical Biology|August 16, 2023
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cellsGladys J Keitany, Benjamin E R Rubin, Meghan E Garrett, et al.
Journal of the Royal Society, Interface|April 6, 2018
Opportunities and obstacles for deep learning in biology and medicineTravers Ching, Daniel S Himmelstein, Brett K Beaulieu-Jones, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Nature Communications|September 28, 2017
Corrigendum: Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancerBi-Dar Wang, Kristin Ceniccola, SuJin Hwang, et al.
Nature Communications|July 1, 2017
Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancerBi-Dar Wang, Kristin Ceniccola, SuJin Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2021
Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 StudyOthman Al-Sawaf, Can Zhang, Tong Lu, et al.
BMC Cancer|July 2, 2020
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myelomaTravers Ching, Megan E Duncan, Tera Newman-Eerkes, et al.
Nature|April 30, 2015
Th17 cells transdifferentiate into regulatory T cells during resolution of inflammationNicola Gagliani, Maria Carolina Amezcua Vesely, Andrea Iseppon, et al.
Cell Chemical Biology|August 16, 2023
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cellsGladys J Keitany, Benjamin E R Rubin, Meghan E Garrett, et al.
Journal of the Royal Society, Interface|April 6, 2018
Opportunities and obstacles for deep learning in biology and medicineTravers Ching, Daniel S Himmelstein, Brett K Beaulieu-Jones, et al.
Pageof 3